focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Imv Polygon certainly won’t be seeking to buy Synairgen.
But I can see the argument that they may be acting on behalf of a big Pharma. The Phase 2 trial demonstrated the value of SNG001. We all know that SNG001 is not a one trick pony re Covid 19. A big pharma could currently buy this therapeutic drug at a snip (for their budgets) and seek to develop it across many medical fronts - COPD & influenza would be just 2 examples. And who knows what other potential uses with their financial muscle?
Referring to the LINE chart which shows 4:30pm closing prices, the sp has been in a downtrend since the high @ circa 36p last June. If we can get to 28p and close, then imv we will have broken free & above the 8 month resistance. No wonder the blockers are keen to prevent this bullish breakout. Just my view of course.
Barbershop the back row should arguably always be premium seating; no kids throwing popcorn down the back of your neck or kicking the back of your seat lol ;)
TommyD great questions there. Shareholders certainly need to be able to understand whether the SNG001 P3 trial ever stood a realistic chance of succeeding (statistically / scientifically) if the playing field was skewered by the apparent dosing of steroids to the trial patients at the same time - thereby negating to a large extent the claim that SNG001 was the benefitting drug - as seen yesterday.
All questions for RM imv.
Colonel while I want to believe that the PFS will be on time - probably late June? The bod won’t be toast as you put it, until December. So a month or 3 delay would likely be water off a ducks back? That said, until proven otherwise, I’m giving our new ceo the full benefit of the doubt that he can and will deliver results in a stated and timely fashion. New broom sweeping …..
Many many heartfelt posts over the last 2 days. Fortunes gone, dreams gone, house deposits gone etc etc. While not apportioning any blame whatsoever, I do hope that Synairgen have been keeping abreast of the posts on this and other platforms, and will be aware of the depth of conviction so many of us had in SNG001 and it’s ability to be a worldwide benefit to millions and millions of Covid sufferers - as well as the obvious financial benefit to our bank accounts. The directors themselves will likely be feeling the same array of emotions too.
I’m very grateful to the knowledgeable posters with great insight on the current state of play (as they see it). Indeed this has been for the most part, a super bulletin board (since I joined just after manic Monday). I’ve felt at home posting my thoughts here and been able to benefit from some stellar research by many posters. Many thanks to all !
For me, I shall continue to hold in the sincere belief that the SNG001 story is far from over. And I shall be looking for comms forthcoming from Synairgen within the next few days updating us where things currently stand and how things will be progressed from here. As someone else noted - surely they will have had contingency plans in place for yesterday’s eventuality. I’m not looking for huge detail but a brief overview - and I’d like it to be in the form of a Q&A with RM.
Gla
I would hazard a guess that Polygon will hold and see what unfolds in the coming days and weeks. Even if their intention was to sell / partly sell, then surely they’d wait and hope for some sort of recovery in the sp before doing so? They clearly had great faith in Synairgen ahead of yesterday’s bombshell, evidenced by their huge holding, and why would that have entirely evaporated? And the naysayers poo poo the idea that they may top up at these prices - but it’s possible. It’s all idle speculation. Let’s see whether any TR1s land, but my guess is that we won’t see any for now from Polygon.
Docdaneeka I’m also trying to understand this difference of ‘standard of care’ between P2 & P3 trials. Were Synairgen aware of this difference during the P3 trial and was this ever communicated to shareholders? Because for me, it seems that the P3 trial was playing on a harder playing field - hence a higher bar to cross - hence greater risk? Shareholders absolutely should be kept in the picture about what risk they are taking with their hard earned money !
Tensions and frustrations are understandably high today after this hugely disappointing P3 news, but I think there are legitimate questions to be answered. Just my opinion of course as a layman, and will happily be corrected if I’m barking up the wrong tree on this standard of care thingy.
I agree with others wanting to hear from Marsden directly (not via RNS) and pronto. Maybe a day or two for the company to dust-down and gather themselves (because their years of work, hopes & dreams have been dealt a huge blow - just like PIs) but then I’d like to hear a frank assessment from him as to where this leaves the company and shareholders moving forward.
Gobsmacked & gutted !!!! Plus very angry if I’m honest. I feel for those PIs with huge holdings - and imagine how Polygon are feeling.
I’ve not sold and will see how the dust settles. One very unhappy PI.
Turbo I sincerely hope you made a profit after 10 years of holding. I can’t say that I blame you for calling it a day, but a shame you couldn’t stomach waiting just a little longer for what we all hope will see significant sp progress. That said, many of us (maybe yourself) are growing grey hairs as we wait and wait and wait !
Best of luck to you.
Val d’Isere & Tignes (effectively one skiing area) provide great skiing and probably the best slopes I’ve skied although many on my list to sample :)
Will be able to amply sample when Synairgen obliges ;D
Andy you’re now saying that we will be lucky to get the results by March?? Really??
With respect, I can only conclude that you are trading this yourself. Your sentiment seems to ebb and flow with the tide every day. I would suggest that you try and get some consistency in your posts - just saying.